Yescarta is a chimeric antigen receptor T cell CAR T therapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.
Active ingredient in Yescarta is axicabtagene ciloleucel, inactive ingredient is albumin (human); DMSO.
Yescarta is a treatment for your non-Hodgkin lymphoma. It is used when you have failed at least two other kinds of treatment. Yescarta is different from other cancer medicines because it is made from the user's white blood cells, which have been modified to recognize and attack the lymphoma cells.
Before you receive Yescarta, you will get three days of chemotherapy to prepare your body. When your Yescarta is ready, your healthcare provider will give it to you through a catheter placed into your vein-intravenous infusion.
Yescarta may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you have fever, difficulty breathing, shaking chills, confusion, dizziness, severe nausea, vomiting, diarrhea, fast or irregular heartbeat, severe fatigue and weakness.
haleplushearty.blogspot.com
No comments:
Post a Comment